A novel micro-linear vector for in vitro and in vivo gene delivery and its application for EBV positive tumors.
BACKGROUND: The gene delivery vector for DNA-based therapy should ensure its transfection efficiency and safety for clinical application. The Micro-Linear vector (MiLV) was developed to improve the limitations of traditional vectors such as viral vectors and plasmids. METHODS: The MiLV which contain...
Main Authors: | Hong-Sheng Wang, Zhuo-Jia Chen, Ge Zhang, Xue-Ling Ou, Xiang-Ling Yang, Chris K C Wong, John P Giesy, Jun Du, Shou-Yi Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3471901?pdf=render |
Similar Items
-
Viral and Cellular MicroRNAs in Regulation of EBV Latency and Oncogenesis
by: Wang, Ling, et al.
Published: (2017) -
The activational mechanisms of the EBV DNase promoter by EBV transactivators,Zta and Rta
by: Cheng, Chih-Ling, et al.
Published: (1998) -
Functional characterization and target exploration of EBV-encoded microRNA ebv-mir-BART4
by: Ju Yin Tsao, et al.
Published: (2008) -
Emerging Themes from EBV and KSHV microRNA Targets
by: Dhivya Ramalingam, et al.
Published: (2012-09-01) -
Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease
by: Elshafa Hassan Ahmed, et al.
Published: (2021-05-01)